News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

RainDance Technologies Unveils Breakthrough In Somatic Cancer Analysis With Thunderbolts™ Sequencing Panel To Profile Actionable Cancer Mutations For Total Sample Cost As Low As $100


2/10/2014 8:05:45 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BILLERICA, Mass.--(BUSINESS WIRE)--RainDance Technologies, Inc., an innovative genomics tools company ‘democratizing’ molecular testing of complex diseases, today announced that it has developed a comprehensive next-generation sequencing (NGS) panel for profiling actionable cancer mutations, enabling researchers to rapidly and cost-effectively analyze precious biopsy specimens. The ThunderBolts™ Cancer Panel targets 49 known cancer genes, including tumor suppressors, hotspots and drug resistance markers, and features industry breakthroughs in performance, sample flexibility, workflow, and cost.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES